It has been proven that kynurenine from tryptophan metabolism in cancer cells can induce the expression of FOXP3, a marker of regulatory T cells (Tregs), by activating the AhR nuclear transform to suppress tumor immunotherapy (Roncador et al., 2005). Here, AHR is linked to neoplasm.